"Production and marketing demand forecast and transformation and upgrading analysis report of Chinese valve manufacturing industry" predicts that the output of valves in China will reach 8.3 million tons in 2019.The annual compound growth rate in the next five years (2019-2023) is about 3.02%, and it is predicted that the output of valves in China will reach 9.35 million tons in 2023.

Valve is used to open and close the pipeline, control the flow direction, adjust and control the parameters of the medium (temperature, pressure and flow) pipeline accessories.From the perspective of industrial chain, the upstream of valve industry corresponds to the industry of industrial raw material production, such as casting, forging, sealing, etc. Casting is the key component of valve production, and its supply efficiency and quality directly determine the delivery cycle of valve manufacturers and the quality of valve products.As a key component of fluid control, valves are widely used in chemical, food, pharmaceutical and other industries are essential basic parts.Among them, users in the pharmaceutical industry pay high attention to the valve market. As drugs are special commodities, their production requirements are very strict, and the requirements for valves they contact are increasing day by day.

According to the "2018-2023 China pharmaceutical industry market foresight and investment strategic planning analysis report" released by qianzhan industry research institute, the total sales revenue and profit of China's pharmaceutical manufacturing industry in 2017 were 2982.6 billion yuan and 351.97 billion yuan respectively, with year-on-year growth of 6.28% and 17.21%.With the improvement of people's health awareness, the expansion of drug demand, the continuous introduction of relevant medical policies, and the continuous improvement of China's pharmaceutical production capacity, the income and profit level of China's pharmaceutical industry will continue to grow in the future.As an indispensable part of the pharmaceutical industry, pharmaceutical valves will also embrace good development opportunities.

At present, the valve products on the market are diverse, different valve structure and application range are different.Among them, mainly used in the pharmaceutical industry are diaphragm valve, plate ball valve, no retention ball valve.

In the clean pipeline system of the pharmaceutical industry, the diaphragm valve, due to its special design, can make the medium in the pipeline will not contact with other pipe fittings outside the gasket, to avoid stagnant water.

The clean inner wall of the valve body of the disc type ball valve is relatively high, among which, the whole package, no dead Angle of the three-disc ball valve is favored in the pharmaceutical industry.However, the disadvantage of the disc ball valve is that the cost is relatively high.

No retention ball valve is also called no dead Angle ball valve, its wall is smooth, clean degree is higher, easy to avoid bacteria breeding, such advantages make it become an indispensable valve in the pharmaceutical industry.

It is expected that with the rapid development of the pharmaceutical industry, the market scale of these pharmaceutical valves is expected to grow, and the competition among enterprises will be more fierce.With the acceleration of the pace of pharmaceutical valve industry restructuring, product quality safety and product brand will become the main factor of pharmaceutical valve competition, the product will develop towards the direction of high technology, high parameters, strong corrosion resistance, high life span, the level and level of valve products is expected to further improve.

According to the data survey, in recent years, China's valve production has maintained a steady growth.In 2017, China's valve output reached 7.86 million tons, with a year-on-year growth of 2.77%.In 2018, China's valve production reached about 8.04 million tons.The output of valves in China is expected to reach 8.3 million tons in 2019, an increase of 5.60% year-on-year.

The import volume of valves in China has fluctuated in recent years.In 2018, China imported 1039.97 million sets of valves, worth 7.328 billion us dollars.From January to May 2019, China imported 406.11 million sets of valves, down 5.1% year-on-year.Imports totaled us $2.876 billion, down 4.6 percent year-on-year.This also proves from the side, the pace of domestic valve to replace imports is accelerating, the power of domestic valve is rising.

It can be seen that China's valve output, import data are relatively satisfactory.But compared with foreign valves, domestic valve industry concentration ratio is low, most of the overall size of enterprises is small, capital, strength and foreign famous enterprise production of valves comparable.And the valve products produced by most enterprises in China are mainly concentrated in the middle and low-end market, and the overall research and development level is not high.

In general, the domestic valve industry is an industry with both opportunities and challenges, although there are many bottlenecks mentioned above, but from the big background, the valve manufacturing industry is gradually transferred from developed countries to developing countries, China has a high cost advantage and resource advantage.And with the downstream pharmaceutical and other industries to expand the demand for valves, domestic valve enterprises technology and quality level is gradually improving, the cost of valve products gradually reduced, the future domestic valve market prospects are very optimistic, domestic valve companies with strong strength are expected to win more business opportunities.